Follow-up report confirms benefits of finasteride therapy

08/26/2013 | AAFP News Now

A New England Journal of Medicine report said follow-up data from a study of finasteride that ended in 2003 showed it can reduce the overall risk of prostate cancer in men who were regularly screened for the disease. The study update confirmed results of the Prostate Cancer Prevention Trial and found that an increased risk of high-grade cancer associated with use of the drug did not have an effect on mortality.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN